The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499 · cited 1×
“A diagnosis of AD was confirmed in 4 males and 2 females by clinical and pathological criteria, in accordance with the NINCDS-ADRDA guidelines (Khachaturian , 1985; McKhann et al., 1984).”
MethodPerry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Korsching, S., Auburger, G., Heumann, R., Scott, J., & Thoenen, H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03791.x · Cited by 938
Appel, S. H. (1981) · Annals of Neurology · doi:10.1002/ana.410100602 · Cited by 698
Characterization and isolation of proteolytically modified nerve growth factor
Mobley, W. C., Schenker, A., & Shooter, E. M. (1976) · Biochemistry · doi:10.1021/bi00670a019 · Cited by 669
Signal transduction by the neutrophin receptors
Kaplan, D. R., & Miller, F. D. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80065-8 · Cited by 583
Human β-nerve growth factor gene sequence highly homologous to that of mouse
Ullrich, A., Gray, A., Berman, C., & Dull, T. J. (1983) · Nature · doi:10.1038/303821a0 · Cited by 480
Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain
McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E., & Nagai, T. (1984) · Neurology · doi:10.1212/wnl.34.6.741 · Cited by 457
Cited by
Neurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298
Neurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Regulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
The molecular basis of retinal ganglion cell death in glaucoma
Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.002 · Cited by 971
Sortilin is essential for proNGF-induced neuronal cell death
Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., Jacobsen, C., Kliemannel, M., Schwarz, E., Willnow, T. E., et al. (2004) · Nature · doi:10.1038/nature02319 · Cited by 962
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820
Neurotrophin Signaling Through the P75 Neurotrophin Receptor
Roux, P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00016-3 · Cited by 717
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691
Self-citationDechant, G., & Barde, Y.-A. (2002) · Nature Neuroscience · doi:10.1038/nn1102-1131 · Cited by 606
Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Mufson, E. J., Counts, S. E., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 587
ProNGF Induces p75-Mediated Death of Oligodendrocytes following Spinal Cord Injury
Beattie, M. S., Harrington, A. W., Lee, R., Kim, J. Y., Boyce, S. L., Longo, F. M., Bresnahan, J. C., Hempstead, B. L., & Yoon, S. O. (2002) · Neuron · doi:10.1016/s0896-6273(02)01005-x · Cited by 414
The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane, Tatiani, Francielle, Michelle, & Alexandra (2015) · Aging and disease · doi:10.14336/ad.2015.0825 · Cited by 407
S ELECTIVITY IN N EUROTROPHIN S IGNALING : Theme and Variations
Segal, R. A. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131421 · Cited by 383
Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344
Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update
Leßmann, V., & Brigadski, T. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.06.004 · Cited by 337
Neurotrophic factors in Alzheimer’s disease: role of axonal transport
Schindowski, K., Belarbi, K., & Buée, L. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00378.x · Cited by 335
A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis
Barbeito, L. H., Pehar, M., Cassina, P., Vargas, M. R., Peluffo, H., Viera, L., Estévez, A. G., & Beckman, J. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.05.003 · Cited by 327
Keefe, K., Sheikh, I., & Smith, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030548 · Cited by 322
Clinical relevance of the neurotrophins and their receptors
Allen, S. J., & Dawbarn, D. (2006) · Clinical Science · doi:10.1042/cs20050161 · Cited by 320
Longo, F. M., & Massa, S. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4024 · Cited by 298
BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses
Gottmann, K., Mittmann, T., & Lessmann, V. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1994-z · Cited by 297
Noble, E. E., Billington, C. J., Kotz, C. M., & Wang, C. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00776.2010 · Cited by 284
Chao, M. V., & Bothwell, M. (2002) · Neuron · doi:10.1016/s0896-6273(01)00573-6 · Cited by 278
Neurotrophic factors and structural plasticity in addiction
Russo, S. J., Mazei-Robison, M. S., Ables, J. L., & Nestler, E. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.059 · Cited by 272
Yune, T. Y., Lee, J. Y., Jung, G. Y., Kim, S. J., Jiang, M. H., Kim, Y. C., Oh, Y. J., Markelonis, G. J., & Oh, T. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1661-07.2007 · Cited by 270
Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury
Harrington, A. W., Leiner, B., Blechschmitt, C., Arevalo, J. C., Lee, R., Mörl, K., Meyer, M., Hempstead, B. L., Yoon, S. O., & Giehl, K. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305755101 · Cited by 269
Volosin, M., Song, W., Almeida, R. D., Kaplan, D. R., Hempstead, B. L., & Friedman, W. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1560-06.2006 · Cited by 265
Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury
Jansen, P., Giehl, K., Nyengaard, J. R., Teng, K., Lioubinski, O., Sjoegaard, S. S., Breiderhoff, T., Gotthardt, M., Lin, F., Eilers, A., et al. (2007) · Nature Neuroscience · doi:10.1038/nn2000 · Cited by 248
Ibáñez, C. F., & Simi, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.007 · Cited by 238
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0481-z · Cited by 224
The p75 neurotrophin receptor: at the crossroad of neural repair and death
Meeker, R. B., & Williams, K. S. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.156967 · Cited by 194
Reimagining cholinergic therapy for Alzheimer’s disease
Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187
Neurotrophins and Proneurotrophins: Focus on Synaptic Activity and Plasticity in the Brain
Gibon, J., & Barker, P. A. (2017) · The Neuroscientist · doi:10.1177/1073858417697037 · Cited by 115
Carlo, A.-S., Gustafsen, C., Mastrobuoni, G., Nielsen, M. S., Burgert, T., Hartl, D., Rohe, M., Nykjaer, A., Herz, J., Heeren, J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2425-12.2013 · Cited by 117
Deciphering Proneurotrophin Actions
Hempstead, B. L. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_2 · Cited by 106
Neuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.117 · Cited by 83
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
Perez, S. E., He, B., Muhammad, N., Oh, K.-J., Fahnestock, M., Ikonomovic, M. D., & Mufson, E. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.002 · Cited by 80
Self-citationPentz, R., Iulita, M. F., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0797-2 · Cited by 68
Ubhi, K., Rockenstein, E., Vazquez‐Roque, R., Mante, M., Inglis, C., Patrick, C., Adame, A., Fahnestock, M., Doppler, E., Novak, P., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23142 · Cited by 65
Self-citationAging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 61
Sorting receptor sortilin—a culprit in cardiovascular and neurological diseases
Carlo, A.-S., Nykjaer, A., & Willnow, T. E. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1152-3 · Cited by 56
Eggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
Salasova, A., Monti, G., Andersen, O. M., & Nykjaer, A. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00576-2 · Cited by 42
Estrogen regulation of neurotrophin expression in sympathetic neurons and vascular targets
Kaur, G., Janik, J., Isaacson, L. G., & Callahan, P. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.084 · Cited by 39
Pentz, R., Iulita, M. F., Mikutra-Cencora, M., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105150 · Cited by 31
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.004 · Cited by 18
Capsoni, S., Arisi, I., Malerba, F., D’Onofrio, M., Cattaneo, A., & Cherubini, E. (2022) · Brain Sciences · doi:10.3390/brainsci12060783 · Cited by 18
Metadata
- Authors
- Fahnestock, M., Michalski, B., Xu, B., & Coughlin, M. D.
- Venue
- Molecular and Cellular Neuroscience
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 18
- Issue
- 2
- Pages
- 210-220
- ISSN
- 1044-7431 (ISSN-L)
- OpenAlex
- W2132590272
- Cited by
- 490
- References
- 52
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.